PharmaMedic /
  • Home
  • Our Services
    • Start-Up
    • Product Launch
    • Product Development
  • Join Us
  • About Us
    • Our Vision
    • Dr Malcolm Barratt-Johnson
  • Resources
  • News
  • Contact Us
PharmaMedic
  • Home
  • Our Services
    • Start-Up
    • Product Launch
    • Product Development
  • Join Us
  • About Us
    • Our Vision
    • Dr Malcolm Barratt-Johnson
  • Resources
  • News
  • Contact Us

Support for Life Sciences in UK Spring Budget 2023 22 Mar 2023

 

The UK’s Spring Budget, announced on 15 March 2023, set out the government’s plans to help businesses, including the life sciences sector. In addition to an enhanced rate of tax relief for loss-making R&D-focused small and medium sized enterprises, companies investing in qualifying main rate plant and machinery can write off the full cost from 1 April 2023 until 31 March 2026 under a 100% First Year Allowance.  

 In terms of the life sciences specifically, the government pledged to provide an extra £10 million of funding for the Medicines and Healthcare products Regulatory Agency (MHRA) over the next two years to help it ‘maximise use of its Brexit freedoms and accelerate patient access to treatments’. The Budget outlines that the MHRA is exploring partnerships with international agencies, such as in the US, Europe and Japan, to provide simple, rapid approvals for medicines and technologies that have received their approval from 2024. The MHRA will also have a swift approval process in place from 2024 for the most impactful new medicines and technologies, such as cancer vaccines and AI therapeutics for mental health. 

 Further measures for science include supporting the new Bedford-Cambridge section of East-West rail to connect R&D hubs in Oxford and Cambridge, along with funding for strategic economic growth around new stations, as the government recognises the need for more laboratory space to support R&D. 

 Read the full Spring Budget via this link. 

 

GeneralCategories

  • No categories

GeneralTags

#ABPI #BIA #cancer #ClinicalTrials #diagnostics #drugdevelopment #drugpricing #drugregulation #EC #EFPIA #EMA #EU #FDA #HTA #innovation #lifesciences #marketaccess #MDR #medicaldevice #medicaldeviceregulation #medicinesaccess #mentalhealth #mhra #NHS #NICE #pharmaregulation #pre-eclampsia #R&D #rarediseaseresearch #rarediseases #regulation #regulatory #research #UKgovernment #ukregulation #VPAS AI Biotech COVID-19 Healthcare IR35 Medical Affairs medicaldevices Pharma UKmedicines
PharmaMedic
  • Home
  • Join Us
  • Our Vision
  • Dr Malcolm Barratt-Johnson
  • Resources
  • News
  • Contact Us
Our Services
  • Start-Up
  • Product Launch
  • Product Development
Legal
  • Privacy Policy
  • Cookie Policy
Contact us
  • T:+44 (0) 208 168 1668
  • US Toll Free:+1 628 201 0911
  • [javascript protected email address]
  • The London Bioscience Innovation Centre (LBIC)
    2 Royal College Street
    London NW1 0NH

©2023 PharmaMedic. All Rights Reserved | Company Registration Number: 07364364 | VAT: 135986768

Powered by FL1 Digital